Merck
-
In A First, FDA OKs Cancer Treatment For Tumors With Specific Genetic Feature
-
Merck Clears Clinical Trial Milestone, Shows Promise With Alzheimer’s Drug Verubecestat
-
FDA Gives Merck Green Light To Market Keytruda Lung Cancer Drug
-
Lung Cancer Treatment: Keytruda Better Than Chemotherapy In Patients With Non-Small Cell Lung Cancer
-
Drugmakers Merck, Allergan Spark Rumors Of Biogen Takeover
-
Hundreds Receive Experimental Merck Ebola Vaccine To Fight Flare-Up In Guinea
-
Federal Jury Orders Gilead To Pay Merck $200 Million In Hepa C Drug Patent Dispute
-
Jury Favors Merck Over Gilead In Hepatitis C Drug Patent Dispute
-
FDA Approves Merck’s Hepatitis C Pill Zepatier
-
Immunotherapy Drug Keytruda More Effective Than Chemotheraphy For Advanced Lung Cancer
-
FDA Gives Approval To Bridion, A Surgery Drug That Reverses The Effects Of Muscle Relaxants
-
Merck's Star Drug Keytruda Improves Overall Survival Of Lung Cancer Patients
Most Popular
